The performance of a point of care test for detection of anti-mutated citrullinated vimentin and rheumatoid factor in early rheumatoid arthritis

Clinical Rheumatology

Volumn 33, Issue 7, 2014, Pages 919-923

  Rojanasantikul, Preeda ^a   Pattrapornpisut, Prapa ^a   Anuruckparadorn, Kulvara ^a   Katchamart, Wanruchada ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anti MCV; Negative predictive value; Positive predictive value; Rheumatoid arthritis; Rheumatoid factor; Sensitivity; Specificity

Indexed keywords

CREATININE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; VIMENTIN; CITRULLINE;

ADULT; ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FALSE POSITIVE RESULT; FEMALE; GOUT; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; OUTPATIENT DEPARTMENT; POINT OF CARE TESTING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; AGED; ARTHRITIS, RHEUMATOID; BLOOD; CHEMISTRY; GENETICS; HOSPITAL INFORMATION SYSTEM; LABORATORY DIAGNOSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; RHEUMATIC DISEASES; RHEUMATOLOGY;

ADULT; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CITRULLINE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES; RHEUMATOID FACTOR; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY; VIMENTIN;

EID: 84903522266     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2544-z     Document Type: Article

References (25)

1. Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 62:2569-2581. doi:10.1002/art.27584
2. Alves C, Luime JJ, van Zeben D et al (2011) Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH). Ann Rheum Dis 70:1645-1647. doi:10.1136/ard.2010.142299
3. Renger F, Bang H, Feist E et al (2010) Immediate determination of ACPA and rheumatoid factor - a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay. Arthritis Res Ther 12:R120. doi:10.1186/ar3057
4. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. doi:10.1002/1529-0131(199709)40:9〈1725::AID-A
5. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980). Arthritis Rheum 23(5):581-590
6. Alarcon-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328-334 (Pubitemid 19104571)
7. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403-407. doi:10.1056/NEJM197502202920807
8. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-347. doi:10.1056/NEJM197502132920706
9. Dougados M, van der Linden S, Juhlin R et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218-1227
10. Wallace SL, Robinson H, Masi AT et al (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895-900
11. Resnick D, Niwayama G, Goergen TG et al (1977) Clinical, radiographic and pathologic abnormalities in calcium pyrophosphate dihydrate deposition disease (CPPD): pseudogout. Radiology 122:1-15 (Pubitemid 8011550)
12. Martel W, McCarter DK, Solsky MA et al (1981) Further observations on the arthropathy of calcium pyrophosphate crystal deposition disease. Radiology 141:1-15 (Pubitemid 11006903)
13. Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039-1049
14. Altman R, Alarcon G, Appelrouth D et al (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505-514
15. Altman R, Alarcon G, Appelrouth D et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601-1610
16. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080
17. Liang MH, Meenan RF, Cathcart ES, Schur PH (1980) A screening strategy for population studies in systemic lupus erythematosus. Series design. Arthritis Rheum 23:153-157 (Pubitemid 10164320)
18. Liang MH, Phillips EE, Scamman MD et al (1981) Evaluation of a pilot program for rheumatic disability in an urban community. Arthritis Rheum 24:937-943 (Pubitemid 11070097)
19. Nishimura K, Sugiyama D, Kogata Y et al (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797-808 (Pubitemid 351650500)
20. Bang H, Egerer K, Gauliard A et al (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 56:2503-2511. doi:10.1002/art.22817 (Pubitemid 47237269)
21. Mathsson L, Mullazehi M, Wick MC et al (2008) Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum 58:36-45. doi:10.1002/art.23188
22. Sghiri R, Bouajina E, Bargaoui D et al (2008) Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis. Rheumatol Int 29:59-62. doi:10.1007/s00296-008-0614-8
23. Damjanovska L, Thabet MM, Levarth EW et al (2010) Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis 69:730-732. doi:10.1136/ard.2009.108456
24. ORGENTEC Diagnostica GmbH Mainz, Germany (2009) Rheumachec® rapid test instructions for use. http://ocd-group.com/rheumachec/projekt01/media/ Flyer/rheumachec-InstructionForUse-ENG-April2009-130309.pdf
25. Bartoloni E, Alunno A, Bistoni O et al (2012) Diagnostic value of antimutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev 11:815-820. doi:10.1016/j.autrev.2012.02.015